86. Pulmonary arterial hypertension Clinical trials / Disease details


Clinical trials : 1,181 Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04915300
(ClinicalTrials.gov)
March 202219/5/2021Apabetalone for Pulmonary Arterial HypertensionApabetalone for Pulmonary Arterial Hypertension: a Phase 2 Clinical StudyPulmonary Arterial HypertensionDrug: Apabetalone;Drug: PlaceboLaval UniversityCanadian Institutes of Health Research (CIHR);Resverlogix CorpNot yet recruiting18 Years75 YearsAll72Phase 2Canada
2NCT03655704
(ClinicalTrials.gov)
August 22, 201928/8/2018Apabetalone for Pulmonary Arterial Hypertension: a Pilot StudyApabetalone for Pulmonary Arterial Hypertension: a Pilot StudyPulmonary Arterial HypertensionDrug: ApabetaloneSteeve ProvencherResverlogix CorpActive, not recruiting18 Years75 YearsAll7Early Phase 1Canada